Cubist Systematic Strategies, LLC Syndax Pharmaceuticals Inc Transaction History

Cubist Systematic Strategies, LLC

$15.1 Billion
Q4 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 358,071 shares of SNDX stock, worth $4.81 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

358,071

Holding current value

$4.81 Million

% of portfolio

0.03%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$12.52 - $21.81 $4.48 Million - $7.81 Million	358,071 New	358,071 $4.73 Million
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $2.79 Million - $4.18 Million	192,094 New	192,094 $2.79 Million
Q1 2023 May 15, 2023	BUY	$20.66 - $28.98 $163,627 - $229,521	7,920 New	7,920 $167,000
Q2 2022 Aug 15, 2022	SELL	$13.64 - $19.48 $788,446 - $1.13 Million	-57,804 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$14.84 - $22.15 $299,857 - $447,562	20,206 Added 53.74%	57,804 $1.01 Million
Q4 2021 Feb 14, 2022	BUY	$15.23 - $22.47 $322,952 - $476,476	21,205 Added 129.35%	37,598 $823,000
Q3 2021 Nov 15, 2021	SELL	$13.87 - $19.8 $66,201 - $94,505	-4,773 Reduced 22.55%	16,393 $313,000
Q2 2021 Aug 16, 2021	BUY	$13.42 - $25.18 $59,249 - $111,169	4,415 Added 26.36%	21,166 $363,000
Q1 2021 May 17, 2021	SELL	$19.28 - $24.59 $341,178 - $435,144	-17,696 Reduced 51.37%	16,751 $375,000
Q4 2020 Feb 16, 2021	BUY	$15.1 - $26.44 $403,879 - $707,190	26,747 Added 347.36%	34,447 $766,000
Q3 2020 Nov 16, 2020	SELL	$13.39 - $17.48 $103,919 - $135,662	-7,761 Reduced 50.2%	7,700 $114,000
Q2 2020 Aug 14, 2020	BUY	$8.94 - $20.98 $138,221 - $324,371	15,461 New	15,461 $229,000
Q4 2018 Feb 14, 2019	SELL	$3.6 - $8.42 $7,718 - $18,052	-2,144 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$6.33 - $8.08 $13,571 - $17,323	2,144 New	2,144 $17,000

Others Institutions Holding SNDX

# of Institutions

232

Shares Held

92.7M

Call Options Held

1.39M

Put Options Held

543K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $760M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Syndax Pharmaceuticals Inc Transaction History